Press "Enter" to skip to content

Sebi may reopen insider trading case against Sun Pharma

Alleged irregularities in raising funds through FCCBs are likely to be probed by the watchdog, said sources.

Original source: https://health.economictimes.indiatimes.com/news/pharma/sebi-may-reopen-insider-trading-case-against-sun-pharma/66890221?utm_source=RSS&utm_medium=ETRSS

Also Read:   AstraZeneca's Lynparza gets EU nod as first-line ovarian cancer maintenance treatment